Allspring Global Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,287
| Closed | -$127K | – | 2266 |
|
|
2024
Q3 | $127K | Sell |
2,287
-1,044
| -31% | -$58K | ﹤0.01% | 1747 |
|
|
2024
Q2 | $137K | Buy |
3,331
+13
| +0.4% | +$534 | ﹤0.01% | 1794 |
|
|
2024
Q1 | $155K | Buy |
3,318
+1,339
| +68% | +$62.5K | ﹤0.01% | 1757 |
|
|
2023
Q4 | $94.6K | Buy |
1,979
+548
| +38% | +$26.2K | ﹤0.01% | 1804 |
|
|
2023
Q3 | $51K | Sell |
1,431
-3
| -0.2% | -$107 | ﹤0.01% | 2264 |
|
|
2023
Q2 | $66.2K | Sell |
1,434
-340
| -19% | -$15.7K | ﹤0.01% | 2200 |
|
|
2023
Q1 | $71.1K | Sell |
1,774
-18
| -1% | -$722 | ﹤0.01% | 2160 |
|
|
2022
Q4 | $83K | Sell |
1,792
-8
| -0.4% | -$371 | ﹤0.01% | 2137 |
|
|
2022
Q3 | $74K | Sell |
1,800
-198
| -10% | -$8.14K | ﹤0.01% | 2195 |
|
|
2022
Q2 | $119K | Sell |
1,998
-435
| -18% | -$25.9K | ﹤0.01% | 1997 |
|
|
2022
Q1 | $176K | Sell |
2,433
-31
| -1% | -$2.24K | ﹤0.01% | 2609 |
|
|
2021
Q4 | $207K | Buy |
+2,464
| New | +$207K | ﹤0.01% | 2624 |
|